cyc 202 has been researched along with Cancer of Head in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellinger, G; Biktasova, A; Gary, C; Hajek, M; Issaeva, N; Yarbrough, WG | 1 |
| Arnett, DG; Burd, R; Hill, GA; Klein, RR; Limesand, KH; Martin, KL | 1 |
| Grandis, JR; Lu, Y; Stehle, C; Steinman, RA; Wentzel, A | 1 |
| Kiyota, A; Matsumura, T; Mihara, M; Shintani, S; Wong, DT | 1 |
4 other study(ies) available for cyc 202 and Cancer of Head
| Article | Year |
|---|---|
Selective antitumor activity of roscovitine in head and neck cancer.
Topics: Animals; Antineoplastic Agents; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Papillomaviridae; Papillomavirus Infections; Protein Kinase Inhibitors; Purines; Roscovitine; Xenograft Model Antitumor Assays | 2016 |
Prevention of radiation-induced salivary gland dysfunction utilizing a CDK inhibitor in a mouse model.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Caspase 3; Cyclin-Dependent Kinases; DNA Primers; DNA Repair; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Mice; Proliferating Cell Nuclear Antigen; Purines; Radiation Injuries, Experimental; Radiotherapy; Real-Time Polymerase Chain Reaction; Roscovitine; Salivary Glands | 2012 |
Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2.
Topics: 3T3 Cells; Animals; Carcinoma, Squamous Cell; CDC2-CDC28 Kinases; Cell Communication; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA-Binding Proteins; Enzyme Inhibitors; ErbB Receptors; Fibroblasts; Head and Neck Neoplasms; Humans; Mice; Mice, Knockout; Phosphorylation; Protein Serine-Threonine Kinases; Purines; rac1 GTP-Binding Protein; Roscovitine; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transforming Growth Factor alpha; Tumor Cells, Cultured; Up-Regulation | 2003 |
Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-x in head and neck squamous cell carcinoma cells.
Topics: Apoptosis; bcl-X Protein; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Gene Expression; Head and Neck Neoplasms; Humans; Proto-Oncogene Proteins c-bcl-2; Purines; Roscovitine; Tumor Cells, Cultured | 2002 |